000 | 01971 a2200577 4500 | ||
---|---|---|---|
005 | 20250517075413.0 | ||
264 | 0 | _c20161220 | |
008 | 201612s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.7032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKang, Hio Chung | |
245 | 0 | 0 |
_aWhole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. _h[electronic resource] |
260 |
_bOncotarget _cFeb 2016 |
||
300 |
_a8321-31 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aExome _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenome, Human |
650 | 0 | 4 |
_aHigh-Throughput Nucleotide Sequencing _xmethods |
650 | 0 | 4 | _aHistone-Lysine N-Methyltransferase |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aLoss of Heterozygosity _xgenetics |
650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
650 | 0 | 4 |
_aMesothelioma _xgenetics |
650 | 0 | 4 | _aMesothelioma, Malignant |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aPleural Neoplasms _xgenetics |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProtein Methyltransferases _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aKim, Hong Kwan | |
700 | 1 | _aLee, Sharon | |
700 | 1 | _aMendez, Pedro | |
700 | 1 | _aKim, James Wansoo | |
700 | 1 | _aWoodard, Gavitt | |
700 | 1 | _aYoon, Jun-Hee | |
700 | 1 | _aJen, Kuang-Yu | |
700 | 1 | _aFang, Li Tai | |
700 | 1 | _aJones, Kirk | |
700 | 1 | _aJablons, David M | |
700 | 1 | _aKim, Il-Jin | |
773 | 0 |
_tOncotarget _gvol. 7 _gno. 7 _gp. 8321-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.7032 _zAvailable from publisher's website |
999 |
_c25682942 _d25682942 |